These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22787804)

  • 1. [Instrumental ADL and basic ADL].
    Toba K; Kimura S; Yamada Y; Machida A; Kozaki K
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():313-8. PubMed ID: 22787804
    [No Abstract]   [Full Text] [Related]  

  • 2. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
    Feldman HH; Schmitt FA; Olin JT;
    Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia in the elderly.
    Nichols ME
    J Med Assoc Ga; 1997 Apr; 86(2):101-3. PubMed ID: 9114655
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
    Wattmo C; Wallin AK; Londos E; Minthon L
    Gerontologist; 2011 Feb; 51(1):17-27. PubMed ID: 20562471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil.
    Hatoum HT; Thomas SK; Lin SJ; Lane R; Bullock R
    J Med Econ; 2009 Jun; 12(2):98-103. PubMed ID: 19492974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetylcholinesterase inhibitor. Helpful not just in Alzheimer dementia].
    MMW Fortschr Med; 2002 Aug; 144(33-34):59. PubMed ID: 12380156
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticholinesterases in the treatment of Alzheimer's dementia--the first year's experience in Argyll & Clyde.
    Hughes A; Coulter F; Gillespie R; Livingston H; Phillips K; Quinn E; Rimmer E; Smith M; Walker A
    Health Bull (Edinb); 2000 Jan; 58(1):20-4. PubMed ID: 12813848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil and Alzheimer's dementia.
    Earl-Slater A; Walley T
    Clin Perform Qual Health Care; 2000; 8(1):47-51. PubMed ID: 11183967
    [No Abstract]   [Full Text] [Related]  

  • 9. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
    Aguglia E; Onor ML; Saina M; Maso E
    Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent development of anti-dementia drugs].
    Hirai S
    No To Shinkei; 2001 Mar; 53(3):235-40. PubMed ID: 11296396
    [No Abstract]   [Full Text] [Related]  

  • 11. [Limited efficacy of cholinesterase inhibitors in Alzheimer's dementia].
    Kornhuber J
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):553-4. PubMed ID: 15472777
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
    Prasher VP; Adams C; Holder R;
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
    [No Abstract]   [Full Text] [Related]  

  • 13. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract]   [Full Text] [Related]  

  • 14. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
    Jones RW; Soininen H; Hager K; Aarsland D; Passmore P; Murthy A; Zhang R; Bahra R
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):58-67. PubMed ID: 14716700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
    Vollmar HC; Butzlaff M
    Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
    [No Abstract]   [Full Text] [Related]  

  • 17. New drug available for Alzheimer's disease.
    Bailey C
    Colo Nurse; 1997 Mar; 97(1):12. PubMed ID: 9095790
    [No Abstract]   [Full Text] [Related]  

  • 18. [Many Alzheimer patients untreated].
    MMW Fortschr Med; 2002 Oct; 144(40):51. PubMed ID: 12449096
    [No Abstract]   [Full Text] [Related]  

  • 19. Donepezil (Aricept) therapy for Alzheimer's disease.
    Geldmacher DS
    Compr Ther; 1997 Jul; 23(7):492-3. PubMed ID: 9262925
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
    Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P
    Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.